| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $720.4M | +20.8% |
| Cost of Revenue | $113.3M | +9.6% |
| Gross Profit | $607.1M | +23.1% |
| R&D Expense | $164.6M | +19.5% |
| SG&A Expense | $180.6M | +7.7% |
| Operating Income | -$138.6M | +18.5% |
| Pre-tax Income | -$90.8M | +26.6% |
| Income Tax | $4.5M | -66.8% |
| Net Income | -$95.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $620.3M | +27.1% |
| Short-term Investments | $449.8M | -35.7% |
| Accounts Receivable | $122.9M | +26.5% |
| Current Assets | $1.27B | -6.6% |
| Total Assets | $1.61B | +10.6% |
| Current Liabilities | $407.7M | +24.6% |
| Total Liabilities | $474.0M | +23.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $160.6M | +86.4% |
| Capital Expenditures | $9.2M | +343.5% |
| Investing Cash Flow | $38.8M | -75.5% |
| Financing Cash Flow | -$67.3M | -11.0% |
| Free Cash Flow | $151.5M | +80.1% |
| +30.6% |
| EPS (Basic) | -$0.32 | +31.9% |
| EPS (Diluted) | -$0.32 | +31.9% |
| Stockholders' Equity |
| $1.14B |
| +6.1% |